Inhibition of TAM family members may be a novel therapeutic approach to treat glioblastoma; therefore we evaluated the phosphorylation state of the TAM family members in response to Foretinib treatment in the adult glioblastoma cell lines, U251 and A172, and the pediatric glioblastoma cell line SF188. This evidence concerns the gene STIM1 and glioblastoma.